Tag: CMS

donald-trump-signing

Impact of “Most Favored Nation” Rx Price Control Executive Order

CHC_general2

Medicare Negotiations Are Now the Law, but How to Implement Them?

CHC_general2

CMS Sticks to Plan: No Aduhelm Coverage Unless in Clinical Trial

CHC_firstamendment3

Appeals Court Questions CMS Rule for DTC Ad List Prices

CHC_firstamendment3

Three Manufacturers and ANA File Suit against CMS over Drug Price Disclosure Rule

CHC_FDA-Regulatory Images2

CMS Final Rule Requiring List Prices in DTC TV Ads Virtually the Same as Original Proposal

CHC_DTCadvertisement2

Despite Industry’s Price Transparency Initiatives, CMS Pushes Proposed Rule Forward

CHC_DTCadvertisement1

Patients: DTC Ad Drug Price Transparency Proposed Rule Needs More Context, Expanded Scope

CHC_FDA-Regulatory Images2

Trade Groups Say CMS Lacks Authority to Mandate Drug Prices in DTC TV Ads